Further supporting this hypothesis is the link between upregulated IL-10 and inhibition of IL-22, which ultimately results in the reduced expression of antimicrobial peptides, bacterial persistence in HS lesions and an attenuated immune response [43]. This evidence concerns the gene IL22 and histiocytic sarcoma.